At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Electrophysiology proceduredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Single-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Technical Performance of the CathVision ECGenius® System.
In Brief
An observational study evaluating Electrophysiology procedure for Cardiac Arrhythmia. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The primary objective is to evaluate the safety and technical performance of the CathVision ECGenius® System. The secondary objective is to benchmark the intracardiac electrogram signal quality compared to commercially available systems in patients undergoing assessment and ablation of cardiac arrhythmias.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrhythmia
CountriesUnited States
CollaboratorsMedicept Inc.
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMar 2022
First PostedMar 2022
Primary CompletionApr 2022
Study CompletionDec 2023
TodayJul 2026
First PostedMar 31, 2022
Enrollment StartMar 29, 2022
Primary CompletionApr 30, 2022
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 4.3 years ago
Interventions
Electrophysiology proceduredevice
Electrophysiology testing and cardiac ablation of arrhythmia